Correction to “Long‐Term Real‐World Survival of Immuno‐ therapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score‐Matched Analysis”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Cancer Genomics and Diagnostics · Lung Cancer Treatments and Mutations
K. Kim, M. Sweeting, L. Jönsson, and N. Wilking, “Long‐Term Real‐World Survival of Immunotherapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score‐Matched Analysis,” Thoracic Cancer 16, no. 1 (2025): e15535.10.1111/1759-7714.15535PMC1172985239806827
Figure 2 has been corrected to include five data labels for “The second line therapy”.
Below is the correct Figure 2.